Latest AIIMS guidelines for COVID-19 management
Medications used to treat COVID-19
Ivermectin
Source: https://www.medpagetoday.com/special-reports/exclusives/88310
Hydroxychloroquine (HCQ)
Source: https://www.sciencenews.org/article/fda-canceled-emergency-use-hydroxychloroquine-covid-19-coronavirus
Remdesivir
Source: https://www.indiatvnews.com/news/india/remdesivir-may-be-dropped-soon-as-there-is-no-proof-of-its-effectiveness-in-treating-covid19-patients-705500
Favipiravir
Source: https://www.thehindu.com/sci-tech/health/glenmark-unveils-oral-antiviral-for-covid-19/article31878134.ece
- Favipiravir was first used against COVID-19 in Wuhan.
- The DCGI (Drug Controller General of India) approved emergency use of Favipiravir for the use of mild and moderate COVID-19 infections in July 2020.
- However, it is not included in the latest clinical guidelines for treatment of COVID-19 published by the AIIMS/ICMR COVID-19 National Task Force.
- Favipiravir is an antiviral that works by preventing the virus from making its own genetic material, thus halting its multiplication
- Early studies have shown that there was 28.7% faster clearance of shedding of the virus from patients who were treated with Favipiravir versus the normal standard of care. However, further large scale studies need to be conducted for more concrete evidence.
Tocilizumab
Source: https://www.freepressjournal.in/mumbai/mumbai-man-desperately-searching-for-covid-19-drug-tocilizumab-duped-of-rs-41500
Steroids
Source: https://theconversation.com/the-evidence-is-in-who-says-corticosteroids-really-do-save-lives-of-people-critically-ill-with-covid-19-145536
Anticoagulants
Source: https://www.stoptheclot.org/about-clots/managing-anticoagulants/
Convalescent Plasma
Source: https://cen.acs.org/pharmaceuticals/biologics/Convalescent-plasma-data-trickle-COVID-19-studies/98/i23
Drugs and management protocol in COVID-19
to download the pdf